Roel D Freriks
Overview
Explore the profile of Roel D Freriks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quist S, Dorsthorst S, Freriks R, Postma M, Hoyng C, van Asten F
Eur J Health Econ
. 2024 Aug;
PMID: 39162892
Objective: Hydroxychloroquine (HCQ) effectively treats autoimmune diseases but prolonged use may lead to retinopathy and subsequent vision loss. Guidelines suggest annual follow-up after 5 years for low-risk and 1 year...
2.
Rama K, de Roo A, Louwsma T, Hofstra H, Gurgel do Amaral G, Vondeling G, et al.
PLoS Negl Trop Dis
. 2024 Jun;
18(6):e0012254.
PMID: 38848443
Background: Chikungunya is a viral disease caused by a mosquito-borne alphavirus. The acute phase of the disease includes symptoms such as fever and arthralgia and lasts 7-10 days. However, debilitating...
3.
Paulissen J, Seddik A, Dunton K, Livings C, van Hulst M, Postma M, et al.
Eur J Health Econ
. 2023 Jul;
25(4):689-699.
PMID: 37486557
Objectives: Trastuzumab deruxtecan (T-DXd) was recently recommended by the Committee for Medicinal Products for Human Use as a treatment for adult patients with unresectable or metastatic HER2-positive breast cancer, who...
4.
Tiozzo G, Louwsma T, Konings S, Vondeling G, Perez Gomez J, Postma M, et al.
Expert Rev Vaccines
. 2023 May;
22(1):410-418.
PMID: 37132424
Background: Evidence-based reassurances addressing vaccine-related concerns are crucial to promoting primary vaccination, completion of the primary series, and booster vaccination. By summarizing and comparing the reactogenicity of COVID-19 vaccines authorized...
5.
Zhu Y, Duan M, Dijk H, Freriks R, Dekker L, Mierau J
BMJ Open
. 2021 Mar;
11(3):e048020.
PMID: 33753448
Objectives: Studies in clinical settings showed a potential relationship between socioeconomic status (SES) and lifestyle factors with COVID-19, but it is still unknown whether this holds in the general population....
6.
Dijk H, Freriks R, Alessie R, Mierau J
BMC Health Serv Res
. 2020 Dec;
20(1):1113.
PMID: 33267875
Background: Previous studies on the persistence of child and adolescent mental healthcare do not consider the role of time-invariant individual characteristics. Estimating persistence of healthcare using standard linear models yields...
7.
Freriks R, Mierau J, Buskens E, Pizzo E, Luijckx G, van der Zee D, et al.
BMC Health Serv Res
. 2020 Feb;
20(1):103.
PMID: 32041670
Background: Authors in previous studies demonstrated that centralising acute stroke care is associated with an increased chance of timely Intra-Venous Thrombolysis (IVT) and lower costs compared to care at community...
8.
Freriks R, Mierau J, van der Schans J, Groenman A, Hoekstra P, Postma M, et al.
MDM Policy Pract
. 2019 Aug;
4(2):2381468319867629.
PMID: 31453364
This study aimed to assess the cost-effectiveness of treatments for attention-deficit/hyperactivity disorder (ADHD) in children through prevention of serious delinquent behavior. Cost-effectiveness was assessed in net-monetary benefit (NMB). To evaluate...